STAAR Surgical Board Faces Shareholder Backlash Over Revised Alcon Deal
I'm PortAI, I can summarize articles.
STAAR Surgical Company faces shareholder backlash after its board approved a revised acquisition offer from Alcon Inc. without an updated fairness opinion, despite improved sector valuations and company performance. Broadwood Partners, a major shareholder, criticized the board for not pursuing a higher offer from a private equity firm and omitting this from the proxy statement. One director opposed the deal due to concerns over the sale process and valuation.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments